Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in to save your work
Pre-market
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverNIKA
HealthcareOQBUSD

NIKA PHARMACEUTICALS INC.

$00123456789.00123456789001234567890.0%
52w low (est.) $0.74$0.84 52w high (est.)
Market data
Market cap
USD806.33M
52w range
USD0.20 - USD0.96
Sector
Healthcare
Data quality
54/100
Quality & efficiency
Moat score
7/100
Run the 10-point checklist before you buy How these numbers are made

About NIKA PHARMACEUTICALS INC.

Nika Pharmaceuticals, Inc. engages in the development and distribution pharmaceutical products for dietary supplements and antiviral drugs in the United States. The company offers ITV-1, TNG, physiolong, carotilen, fructin, dry boza, anthocylen C, hypocholestin, biodetoxin, silymaron, and solamentum products. The company was formerly known as Centennial Growth Equities Inc. and changed its name to Nika Pharmaceuticals, Inc. in May 2022. Nika Pharmaceuticals, Inc. was incorporated in 2000 and is based in Henderson, Nevada.

Valuation

ValueGrowthProfitHealthIncome23QUALITY
Overall Rating
17
Sell
Sell

Derived from filed metrics · Moderate confidence (54% of the inputs available)

Moat Score7
DCF Intrinsic Value
Not covered by our valuation model yet.

Moat, DCF and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
USD806.33M
P/E Ratio
N/A
Dividend Yield
0.00%
Revenue Growth
0.0%
Profit Margin
0.0%
ROE
0.0%
Debt / Equity
0.00
Beta
-2.48
vs Healthcare sector:Moat 7 vs 7Yield 0.00% vs 0.3%

Statistics

Similar Stocks · Healthcare

LLY73
$920.00+0.7%
AZN.L72
£105.20+0.6%
UNH71
$492.10+1.6%
JNJ70
$146.20-0.2%

Latest News · NIKA